Skip to content
Search

Latest Stories

Superdrug criticised for rolling out £69 antibody kit which wasn't 'intended for use as a home test'

Superdrug has been criticised for “profiteering from a pandemic” by charging £69 for a home antibody test for coronavirus.

The manufacturer of the test, Abbott, said it was not a DIY kit to test for Covid-19 antibodies.


“The test is not intended for use as a home test and it should not be conducted with a finger stick blood sample,” the company told Pharmacy Business in a statement on Thursday (May 21).

Pharmacy Business did ask Superdrug if the company would consider discontinuing the antibody home testing kit in light of what the manufacturers have said, but there was no response.

A member of parliament who also chairs the lawmakers’ panel on consumer protection has lambasted the health and beauty retailer for “playing on people’s fears.”

Yvonne Fovargue MP said: “£70 with postage for a test which is not completely accurate seems excessive.

“Superdrug seems to be playing on people’s fears and that’s not right. What people really need is a readily available, easy to use test that’s accurate. They deserve nothing less.”

Fovargue supports the use of community pharmacies for testing because “they have both the expertise and knowledge of their communities, which puts them in an ideal position to both test and discuss any issues.”

Superdrug launched the Covid-19 antibody testing kit on Wednesday (May 20) but there were concerns over accuracy of results which Superdrug put down at 97.5 per cent.

This comes amid growing public interest on how the Roche antibody tests, when they are finally made available to the public, will contribute to the Government strategy on easing the ongoing lockdown.

Users of the Superdrug test would need to prick their finger at home with a lancet before collecting a few drops of blood in a vial to send the sample to be tested at an accredited laboratory via prepaid post.

However, Abbott Laboratories told Pharmacy Business that the test was meant for laboratory use only.

“Abbott’s Architect SARS-CoV-2 test was developed for use by laboratory professionals only. The Abbott test has been validated for use with a venous blood sample that is taken by a healthcare provider.

“When used appropriately with a venous blood sample, the Abbott test has demonstrated 99.6% specificity and 100% sensitivity to detect IgG antibodies for patients tested 14 days after symptoms started.

“Abbott has been, and continues to be, very clear with our existing laboratory customers about the intended use of this test and that Abbott is unable to give any guarantees or make claims for the performance of our test if it is used with finger stick blood.

“Abbott does not have any data to support that finger stick blood samples can be used with our test.”

In a written statement to Pharmacy Business, Superdrug said: “The laboratory partner that we work closely with to supply this test has provided evidence of validation of the use of a capillary blood sample.

“As a UKAS accredited laboratory, TDL have a responsibility to carry out validation test, they conducted an internal study using sample provided from patients that have previously tested positive using a PCR swab test to Corona Virus (SARS-CoV-2).

The statement added that the chain's Online Doctor service “provides a home sampling test where a blood test is taken at home but analysed at a UKAS-accredited laboratory.”

While launching the Covid-19 antibody test on Wednesday, Superdrug’s Healthcare Director Michael Henry reportedly said it was Public Health England-approved and that the retail chain was “confident of its accuracy and reliability.”

"PHE has not evaluated any lab-based tests that involve people taking their own blood sample at home," a spokesperson told Pharmacy Business on Thursday, charifying that it "does not issue accreditation of any testing laboratories or provide approvals, validations or endorsements of any particular products including any COVID-19 diagnostic assay."

The Medicines and Healthcare products Regulatory Agency (MHRA) said: "The link between the presence of antibodies and immunity is not proven, and some tests are not specific for COVID-19 antibodies."

“Any antibody test at present can only provide a partial picture, echoed Gino Martini, Chief Scientist at the Royal Pharmaceutical Society.

“The real issue is that no-one knows the level of immunity that is conferred by having antibodies to coronavirus, how long it might last, and if you can become re-infected.

“We need much more information and data on immunity before we can understand the importance of having antibodies to the virus.”

The government has held the view that a positive test result for antibodies does not necessarily mean that the person being tested is immune to COVID-19. Superdrug have maintained that those who test positive, i.e. have antibodies, should still adhere to the Government’s social distancing guidelines.

This has led many to wonder the purpose of the test and the rationale behind the pricing, although Superdrug has said that the price is “reflective of the cost.”

The story has generated a lot of interest on social media platforms inclucing Twitter where a user Craig Fleming tweeted that Superdrug was "preying on peoples anxieties."

https://twitter.com/craigfleming_/status/1263172615205773313

Others also expressed concern over the price:

https://twitter.com/LauraJDawson26/status/1263140808015908878

More For You

NICE approves once-daily tablet Linzagolix for endometriosis

NICE recommends Linzagolix with add-back therapy for endometriosis

Image credit: Getty Images

NICE approves new at-home treatment for endometriosis

The National Institute for Health and Care Excellence (NICE) has recommended Linzagolix (brand name Yselty), a once-daily tablet, as a new treatment option for endometriosis.

Developed by Theramex, Linzagolix is approved for use alongside hormonal add-back therapy in adults of reproductive age who have previously tried other medical or surgical treatments for the condition.

Keep ReadingShow less
Many patients report inaccuracies or missing details in their NHS medical records

Inaccurate information can result in serious harm or even death, warns Healthwatch England.

Image Credit: Getty Images

1 in 4 adults have spotted errors in their NHS medical records, survey finds

Healthwatch England has raised the alarm over the risks posed by inaccurate medical records as research reveals widespread errors in NHS patient information.

Commissioned by Healthwatch England and conducted by BMG Research, the survey polled a representative sample of 1,800 adults in England between 24 and 27 March 2025.

Keep ReadingShow less
Pharmacies NHS weight loss jabs

Pharmacies already sell the medication as a private service

Pic credit: iStock

Pharmacies in line to roll out NHS weight loss jabs

Pharmacies are “best placed” to deliver a planned rollout off greater access to weight loss jabs which could benefit 3.4 million people in England.

Reports today claim the government is looking at trials that would see the medication made available following a short, over-the-counter consultation for the price of an NHS prescription.

Keep ReadingShow less
Numark welcomes hub and spoke change, but calls for clear economic model

The H Human Medicines Regulations amendments will come into force on 1 October 2025.

Image credit: Getty Images

Hub and spoke dispensing between separate pharmacy businesses to begin in October

Community Pharmacy England (CPE) has confirmed that the government has laid amendments to the Human Medicines Regulations 2012 (HMR) in Parliament, marking a crucial step towards enabling hub and spoke dispensing between separate community pharmacy businesses.

The Human Medicines (Amendments Relating to Hub and Spoke Dispensing etc.) Regulations 2025 are set to come into force on 1 October 2025.

Keep ReadingShow less
Lib Dems condemn rising unsolved crimes, say shoplifting and burglary ‘effectively decriminalised’

Leicestershire police recorded the lowest charge rate for shoplifting in the country.

Gettyimages

Shoplifting and burglary ‘effectively decriminalised’, warn Lib Dems as unsolved crimes soar

The Liberal Democrats have raised alarm over what they describe as the “decriminalisation” of burglary and shoplifting, as new data reveals that the vast majority of such offences across Britain are going unsolved.

Figures revealed by the House of Commons Library research, commissioned by the party, showed that only 5.25 per cent of shoplifting offences in London last year led to a suspect being charged.

Keep ReadingShow less